Study of UltomirisĀ® (Ravulizumab) Safety in Pregnancy
Recruiting
75 enrolled
AQUALIS
Recruiting
120 enrolled
PRECIOUS Egypt
Recruiting
200 enrolled
Met Non Small Cell Cancer Registry (MOMENT)
Recruiting
700 enrolled
REFINE-IO
Recruiting
300 enrolled
TARA
Recruiting
1,000 enrolled
REPOWER
Recruiting
3,000 enrolled
ON-TRK
Recruiting
150 enrolled
NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes
Recruiting
100 enrolled
A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection
Recruiting
202 enrolled
A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).
Recruiting
600 enrolled
An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
Recruiting
600 enrolled
Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia
Recruiting
450 enrolled
Lythesia
Recruiting
30 enrolled
Close2HER
Recruiting
100 enrolled
MoMMent
Recruiting
300 enrolled
A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma
Recruiting
8 enrolled
PROVIDENCE
Recruiting
132 enrolled
REALiTEC/TAL
Recruiting
900 enrolled
QOLIBRI
Recruiting
180 enrolled
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Recruiting
500 enrolled
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
Recruiting
350 enrolled
LEPIDOPTERA
Recruiting
380 enrolled
Nova-sTAR
Recruiting
150 enrolled
OBSAPA
Recruiting
270 enrolled
PROACTION:
Recruiting
4,500 enrolled
Double-DARE
Recruiting
1,400 enrolled
Bladder EpiCheck Product Development Study
Recruiting
1,000 enrolled
A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test
Recruiting
15,000 enrolled
LARCS
Recruiting
512 enrolled
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Recruiting
500 enrolled
FRUQUENT
Recruiting
150 enrolled
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Recruiting
800 enrolled
GlofitReal
Recruiting
300 enrolled
Active Surveillance SNEP Assay Registry Trial for Prostate Cancer
Recruiting
2,000 enrolled
MK-3475-U01
Recruiting
1,065 enrolled
TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)
Recruiting
200 enrolled
DREAM
Recruiting
200 enrolled
Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China
Recruiting
14,000 enrolled
Fabry Disease Registry & Pregnancy Sub-registry
Recruiting
9,000 enrolled
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
Recruiting
40 enrolled
BETTER-UAE
Recruiting
100 enrolled
CAROLEEN
Recruiting
3,250 enrolled
IMPULSE
Recruiting
240 enrolled
ENAiBLE
Recruiting
500 enrolled
Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
Recruiting
150 enrolled
AUDIBLE
Recruiting
800 enrolled
SIRI
Recruiting
1,500 enrolled
CERISE
Recruiting
200 enrolled
Real-World Treatment Study of Koselugo (Selumetinib)
Recruiting
200 enrolled